Literature DB >> 31404721

Tyrosol, a simple phenol from EVOO, targets multiple pathogenic mechanisms of neurodegeneration in a C. elegans model of Parkinson's disease.

Jesús Calahorra Garcia-Moreno1, Montserrat Porta de la Riva2, Esther Martínez-Lara1, Eva Siles1, Ana Cañuelo3.   

Abstract

Parkinson's disease (PD) is a common neurodegenerative disorder involving α-synuclein (α-syn) aggregation, oxidative stress, dysregulation of redox metal homeostasis, and neurotoxicity. Different phenolic compounds with known antioxidant or antichelating properties have been shown to also interfere with aggregation of amyloid proteins and modulate intracellular signaling pathways. The present study aims to investigate for the first time the effect of tyrosol (TYR), a simple phenol present in extra-virgin olive oil, on α-syn aggregation in a Caenorhabditis elegans model of PD and evaluate its potential to prevent α-syn toxicity, neurodegeneration, and oxidative stress in this model organism. Our results show that TYR is effective in reducing α-syn inclusions, resulting in a lower toxicity and extended life span of treated nematodes. Moreover, TYR delayed α-syn-dependent degeneration of dopaminergic neurons in vivo. TYR treatment also reduced reactive oxygen species level and promoted the expression of specific chaperones and antioxidant enzymes. Overall, our study puts into perspective TYR potential to be considered as nutraceutical that targets pivotal causal factors in PD.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  C. elegans; Chaperones; Parkinson's disease; Reactive oxygen species; Tyrosol; α-synuclein

Mesh:

Substances:

Year:  2019        PMID: 31404721     DOI: 10.1016/j.neurobiolaging.2019.07.003

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  9 in total

1.  Oxidative Stress Protection by Canary Seed (Phalaris canariensis L.) Peptides in Caco-2 Cells and Caenorhabditis elegans.

Authors:  Uriel Urbizo-Reyes; Kee-Hong Kim; Lavanya Reddivari; Joseph M Anderson; Andrea M Liceaga
Journal:  Nutrients       Date:  2022-06-10       Impact factor: 6.706

2.  An Olive-Derived Extract 20% Rich in Hydroxytyrosol Prevents β-Amyloid Aggregation and Oxidative Stress, Two Features of Alzheimer Disease, via SKN-1/NRF2 and HSP-16.2 in Caenorhabditis elegans.

Authors:  Jose M Romero-Márquez; María D Navarro-Hortal; Victoria Jiménez-Trigo; Pedro Muñoz-Ollero; Tamara Y Forbes-Hernández; Adelaida Esteban-Muñoz; Francesca Giampieri; Irene Delgado Noya; Pedro Bullón; Laura Vera-Ramírez; Maurizio Battino; Cristina Sánchez-González; José L Quiles
Journal:  Antioxidants (Basel)       Date:  2022-03-25

3.  Foldamers reveal and validate therapeutic targets associated with toxic α-synuclein self-assembly.

Authors:  Jemil Ahmed; Tessa C Fitch; Courtney M Donnelly; Johnson A Joseph; Tyler D Ball; Mikaela M Bassil; Ahyun Son; Chen Zhang; Aurélie Ledreux; Scott Horowitz; Yan Qin; Daniel Paredes; Sunil Kumar
Journal:  Nat Commun       Date:  2022-04-27       Impact factor: 17.694

4.  Maackiain Ameliorates 6-Hydroxydopamine and SNCA Pathologies by Modulating the PINK1/Parkin Pathway in Models of Parkinson's Disease in Caenorhabditis elegans and the SH-SY5Y Cell Line.

Authors:  Rong-Tzong Tsai; Chia-Wen Tsai; Shih-Ping Liu; Jia-Xin Gao; Yun-Hua Kuo; Pei-Min Chao; Huey-Shan Hung; Woei-Cherng Shyu; Shinn-Zong Lin; Ru-Huei Fu
Journal:  Int J Mol Sci       Date:  2020-06-23       Impact factor: 5.923

Review 5.  Targeting α-synuclein for PD Therapeutics: A Pursuit on All Fronts.

Authors:  Margaux Teil; Marie-Laure Arotcarena; Emilie Faggiani; Florent Laferriere; Erwan Bezard; Benjamin Dehay
Journal:  Biomolecules       Date:  2020-03-03

6.  Antioxidative Activity of 1,3,5-Triazine Analogues Incorporating Aminobenzene Sulfonamide, Aminoalcohol/Phenol, Piperazine, Chalcone, or Stilbene Motifs.

Authors:  Eva Havránková; Nikola Čalkovská; Tereza Padrtová; Jozef Csöllei; Radka Opatřilová; Pavel Pazdera
Journal:  Molecules       Date:  2020-04-14       Impact factor: 4.411

Review 7.  Oxidative Stress in Parkinson's Disease: Potential Benefits of Antioxidant Supplementation.

Authors:  Sandro Percário; Aline da Silva Barbosa; Everton Luiz Pompeu Varela; Antônio Rafael Quadros Gomes; Michelli Erica Souza Ferreira; Thayana de Nazaré Araújo Moreira; Maria Fani Dolabela
Journal:  Oxid Med Cell Longev       Date:  2020-10-12       Impact factor: 6.543

Review 8.  Potential therapeutic effects of polyphenols in Parkinson's disease: in vivo and in vitro pre-clinical studies.

Authors:  Claudio Giuliano; Silvia Cerri; Fabio Blandini
Journal:  Neural Regen Res       Date:  2021-02       Impact factor: 5.135

Review 9.  Protection against Amyloid-β Oligomer Neurotoxicity by Small Molecules with Antioxidative Properties: Potential for the Prevention of Alzheimer's Disease Dementia.

Authors:  Wataru Araki; Fuyuki Kametani
Journal:  Antioxidants (Basel)       Date:  2022-01-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.